Table 3.
Ranking of risks and percentages of participants who quoted the risk
| Rank | Type of risks mentioned as ‘feared the most’ | Percentage of participants (caregiver percentage) |
|---|---|---|
| 1 | Damage to the liver, kidneys or eyes | 42 (26) |
| 2 | Emotional or behavioral effects such as insomnia, anxiety, depression and irritability | 20 (36) |
| 3 | Heart-related effects such as chest pain or palpitations | 15 (50) |
| 4 | All of them | 7 (50) |
| 5 | Stomach or gut effects such as nausea, lack of appetite and diarrhea | 5 (67) |
| 6 | Other (i.e. as elicited directly from the participant) | 5 (25) |
| 7 | Headaches or pain in the muscle or bone | 4 (0) |
| Tolerated risks in the return of potential benefits | ||
| 1 | Headaches or pain in the muscle or bone | 40 (40) |
| 2 | Stomach or gut effects such as nausea, lack of appetite and diarrhea | 30 (40) |
| 3 | Heart-related effects such as chest pain or palpitations | 10 (33) |
| 4 | Emotional or behavioral effects such as insomnia, anxiety, depression and irritability | 10 (25) |
| 5 | Damage to the liver, kidneys or eyes | 5 (50) |
| 6 | All of them | 5 (0) |